AVAX: Why August will make AVAX Millionaires.
1 extracted signal · 0 resolved · 1 still active
Altcoin DoctorIndependent analyst profile- Source published
- 09 Aug 2026, 05:41 UTC
- Recorded by Tahlil Plus
- 09 Aug 2026, 05:43 UTC
AI-generated source summary
The analysis focuses on the historical performance of Avalanche (AVAX) and the total cryptocurrency market cap excluding Bitcoin, Ethereum, and stablecoins. The speaker highlights that periods where the total crypto market cap (excluding major coins) has reached its lowest points, indicated by a green signal on an indicator, have historically preceded significant bull runs. For AVAX, the speaker suggests that current price levels around $6.52, following a downtrend, may present a buying opportunity, with a target of $10.00 and a failure bound at $5.00, indicating a bullish outlook. The total crypto market cap (excluding major coins) is currently showing consolidation patterns similar to previous cycle bottoms, suggesting a potential upward trend is imminent, with a target around $1.2 trillion and a failure bound at $800 billion. The analysis relies on identifying historical accumulation zones and correlating them with potential future market movements based on past cycles.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Altcoin Doctor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.